Unique Ingredient Identifier EX438O2MRT is listed as a ingredient substance
| RN | 51274-00-1 |
| EC | 257-098-5 |
| NCIT | C75671 |
| RXCUI | 1305582 |
| MF | Fe.O.HO.H2O |
| INCHI KEY | LDHBWEYLDHLIBQ-UHFFFAOYSA-M |
| SMILES | O.[OH-].[O--].[Fe+3] |
UNII EX438O2MRT FERRIC OXIDE YELLOW is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| BUCCAL | FILM | 0.27 MG |
| BUCCAL | TABLET | 1 MG |
| INHALATION | POWDER | 0.04 MG |
| ORAL | CAPSULE | 1.05 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE) | NA |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), HARD GELATIN | 0.17 MG |
| ORAL | CAPSULE, COATED | 0.0115 MG |
| ORAL | CAPSULE, DELAYED ACTION | 0.68 MG |
| ORAL | CAPSULE, DELAYED ACTION, ENTERIC COATED | NA |
| ORAL | CAPSULE, DELAYED RELEASE | 0.42 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | NA |
| ORAL | CAPSULE, EXTENDED RELEASE | 1.67 MG |
| ORAL | CAPSULE, HARD GELATIN | 0.41 MG |
| ORAL | CAPSULE, SOFT GELATIN | 1.23 MG |
| ORAL | CAPSULE, SOFT GELATIN LIQUID-FILLED | 0.1 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 3.04 MG |
| ORAL | GRANULE, FOR ORAL SUSPENSION | 1.8 MG |
| ORAL | GRANULE, FOR RECONSTITUTION | 0.25 MG |
| ORAL | PELLET | 1.8 MG |
| ORAL | POWDER, FOR ORAL SOLUTION | 0.38 MG |
| ORAL | POWDER, FOR SUSPENSION | 0.45 g |
| ORAL | SOFT CAPSULE DOSAGE FORM | 0.123 mg |
| ORAL | SUSPENSION, SUSTAINED ACTION | 0.04 MG/.20684GM |
| ORAL | TABLET | 0.24 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 2.02 MG |
| ORAL | TABLET, CHEWABLE | 0.7 mg |
| ORAL | TABLET, COATED | 0.38 MG |
| ORAL | TABLET, CONTROLLED RELEASE | 0.93 MG |
| ORAL | TABLET, DELAYED ACTION | 0.4 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 0.43 MG |
| ORAL | TABLET, DELAYED RELEASE | 0.2 mg |
| ORAL | TABLET, EXTENDED RELEASE | 3 MG |
| ORAL | TABLET, FILM COATED | 11.5 MG |
| ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 2.42 MG |
| ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 1.96 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 1.5 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 0.32 mg |
| ORAL | TABLET, SUSTAINED ACTION | 3 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 0.065 MG |
| ORAL-20 | TABLET | 2 mg |
| SUBLINGUAL | TABLET | 1 MG |